How Much Are Pharmaceutical Marketing & Sales Capabilities Really Worth?
- Topics:
- Pharmeceuticals
- Tags:
- Accenture Ltd.,
- Marketing,
- Marketing Research,
- Pharmaceutical Company,
- Sales,
- Sales Force Management,
- Sales Strategy
- Source:
- Accenture
FREE Registration is required
Overview: The best performing pharmaceutical companies in Europe are unequivocally differentiated by the success of their marketing and sales capabilities. Approximately 70% of the difference in return on sales between companies can be explained in this way, making marketing and sales highly potent indicators of financial performance. In an average European country operation with a turnover of $300 - 500 million, this difference could represent an additional marketing contribution of $40 - 70 million.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 180KB | Date: Jan 2006 | Pages: 36



